Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

NCT00004409 is registered in ClinicalTrials.gov with State University of New York as lead sponsor.

NCT NCT00004409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
Lead sponsor
State University of New York
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1995
Completion date
April 30, 2004
Enrollment
36 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dupuytren's contracture